Search company, investor...
Applied BioMath company logo

Applied BioMath

Founded Year



Loan | Alive

Total Raised


Last Raised

$680K | 3 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+20 points in the past 30 days

About Applied BioMath

Applied BioMath specializes in mechanistic, mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies.

Headquarters Location

561 Virginia Road Suite 220

Concord, Massachusetts, 01742,

United States


Missing: Applied BioMath's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Applied BioMath's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Applied BioMath

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Applied BioMath is included in 2 Expert Collections, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Digital Health

12,603 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Applied BioMath Patents

Applied BioMath has filed 1 patent.

The 3 most popular patent topics include:

  • Abandoned drugs
  • Artificial intelligence
  • Experimental cancer drugs
patents chart

Latest Applied BioMath News

Applied BioMath, LLC Presents Antibody Drug Conjugates Quantitative Systems Pharmacology Platform Model at the Next-Generation Conjugates Summit

Feb 16, 2023

News provided by Share this article Share this article CONCORD, Mass., Feb. 16, 2023 /PRNewswire/ -- Applied BioMath ( ), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), today announced their participation at the Next-Generation Conjugates Summit occurring February 21-23, 2023 in Boston, MA. Joshua Apgar, PhD, Co-founder and CSO of Applied BioMath will present, "More than the Sum of Their Parts: Integrating data and knowledge of ADCs in a QSP platform model to predict efficacy and toxicity" on Wednesday, February 22nd at 2:00 p.m. In this presentation, Dr. Apgar will discuss how quantitative systems pharmacology (QSP) modeling can help guide antibody drug conjugate (ADC) design and development by creating a platform to guide design properties and understand the therapeutic window. Applied BioMath was awarded a grant in June 2020 by the National Institutes of Health for an ADC platform model to facilitate efficient knowledge discovery and enable rapid knowledge qualification in support of QSP models for ADC projects. "ADCs are a targeted therapy for cancer treatment with clinical validation in a range of cancer types," said John Burke, PhD, Co-founder, President and CEO of Applied BioMath. "They are an exciting modality, but design properties can be counter-intuitive. An ADC QSP platform model provides a holistic model that can describe the mechanism of action for all known ADCs to help navigate the design complexities." To learn more about Applied BioMath, visit . About Applied BioMath Founded in 2013, Applied BioMath's mission is to revolutionize drug invention. Applied BioMath applies biosimulation, including quantitative systems pharmacology, PKPD, bioinformatics, machine learning, clinical pharmacology, and software solutions to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk therapeutic research and development. Their approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through all phases of clinical trials. The Applied BioMath team leverages their decades of expertise in biology, mathematical modeling and analysis, high-performance computing, and industry experience to help groups better understand their therapeutic, its best-in-class parameters, competitive advantages, patients, and the best path forward into and in the clinic to increase likelihood of clinical concept and proof of mechanism, and decrease late stage attrition rates. For more information about Applied BioMath and its services and software, visit . The grant referenced in this press release is supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number R44GM134790. The content is solely the responsibility of Applied BioMath, LLC and does not necessarily represent the official views of the National Institutes of Health. Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC. Press contact:

Applied BioMath Frequently Asked Questions (FAQ)

  • When was Applied BioMath founded?

    Applied BioMath was founded in 2013.

  • Where is Applied BioMath's headquarters?

    Applied BioMath's headquarters is located at 561 Virginia Road, Concord.

  • What is Applied BioMath's latest funding round?

    Applied BioMath's latest funding round is Loan.

  • How much did Applied BioMath raise?

    Applied BioMath raised a total of $1.64M.

  • Who are the investors of Applied BioMath?

    Investors of Applied BioMath include Paycheck Protection Program and True Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.